{ }
001122334455554433221100
001122334455554433221100

abbott laboratories receives buy rating from ubs amid strong product sales

Abbott Laboratories, a leader in pharmaceutical and medical product development, has received a Buy rating from UBS. The company's net sales are primarily derived from diagnostic systems (39.1%) and vascular devices (24.7%), with significant contributions from nutritional products (12.1%) and medical products (8.2%). Geographically, the United States accounts for 38.5% of sales, followed by Germany (5.8%) and China (5.6%).
17:14 17.10.2024

top medical device stocks and etfs to watch in 2024

Johnson & Johnson, a leading medical device maker, has expanded its business through acquisitions and recently spun off its consumer health unit, KenVue. The company is known for its consistent dividend growth, having increased payouts for 62 consecutive years.TransMedics Group, a small-cap company, is innovating organ transport with its Organ Care System, which enhances the viability of donor organs during transit. The company anticipates significant revenue growth in 2024.For investors interested in medical devices, several ETFs are available, including the iShares U.S. Medical Devices ETF and the SPDR S&P Health Care Equipment ETF, which provide diversified exposure to the sector.

global consumer healthcare market projected to reach 575 billion by 2032

The global consumer healthcare market, valued at USD 303.37 billion in 2023, is projected to reach USD 575.40 billion by 2032, growing at a CAGR of 7.51%. This growth is driven by increasing awareness of wellness products and the rising demand for e-commerce platforms, particularly in North America, which holds the largest market share. Key players include Abbott Laboratories, Bayer AG, and Johnson & Johnson Services Inc.

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.